Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Curevac

Clinical trials sponsored by Curevac, explained in plain language.

Now part of BioNTech SE BNTX NASDAQ

Develops mRNA-based vaccines and therapeutics.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet finished but already full! 1 Completed 1

MRNA vaccine takes on glioblastoma in first human trial

Disease control Completed

This early-phase trial tested an mRNA vaccine called CVGBM in 37 people with a fast-growing brain cancer called glioblastoma. Participants had already had surgery and radiation. The vaccine aims to train the immune system to attack remaining cancer cells. The main goal was to che…

Phase: PHASE1 • Sponsor: CureVac • Aim: Disease control

Last updated Jun 27, 2026 09:05 UTC